Publikationen


2018 Impact Factor
1. Danielzik T, Koldehoff M, Buttkereit U, Beelen DW, Horn PA, Lindemann M. Sensitive detection of rare antigen specific T cells directed against Wilms’ tumor 1 by FluoroSpot assay. Leukemia & Lymphoma 2018;59(2):490-2. 2.8
2017 Impact Factor
1. Steens J, Zuk M, Benchellal M, Bornemann L, Teichweyde N, Hess J, Unger K, Görgens A, Klump H and Klein D. In Vitro Generation of Vascular Wall-Resident Multipotent Stem Cells of Mesenchymal Nature from Murine Induced Pluripotent Stem Cells. Stem Cell Reports. 2017;8:919-32  
   
2. Willuweit K, Heinold A, Rashidi-Alavijeh J, Heinemann FM, Horn PA, Paul A, Gerken G, Herzer K. Immunosuppression with mTOR inhibitors prevents the development of donor-specific antibodies after liver transplant. Clin Transplant. 2017 Jun;31(6) 1.8
   
3. Ziemann M, König IR, Lachmann N, Dick A, Ditt V, Budde K, Reinke P, Eisenberger U, Suwelack B, Klein T, Westhoff TH, Arns W, Ivens K, Habicht A, Stippel D, Bös D, Nitschke M, Feldkamp T, Heinemann FM* and Kelsch R*. Unacceptable human leucocyte antigens for organ offers in the era of organ shortage: Influence on waiting time before kidney transplantation. Nephrol Dial Transplant. 2017 May 1;32(5):880-9 4.1
   
4. Giebel B. On the function and heterogeneity of extracellular vesicles. Ann Transl Med. 2017 Mar;5(6):150.  
   
5. Becker J, Horn PA, Keyvani K, Metz I, Wegner C, Brück W, Heinemann FM, Schwitalla JC, Berlit P, Kraemer M. Primary Central Nervous System Vasculitis and its mimicking diseases − clinical features, outcome, comorbidities and diagnostic results − a case control study. Clin Neurol Neurosurg. 2017 May;156:48-54 1.2
   
6. Thöns C, Senff T, Hydes T, Manser A, Heinemann FM, Heinold A, Heilmann M, Kim AY, Uhrberg M, Scherbaum N, Lauer GM, Khakoo SI, Timm J. HLA-Bw4 80(T) and multiple HLA-Bw4 copies combined with KIR3DL1 associate with spontaneous clearance of HCV infection in people who inject drugs. J Hepatol. 2017 Sep;67(3):437-58 10.6
   
7. Buechter M, Manka P, Heinemann FM, Lindemann M, Juntermanns B, Canbay A, Gerken G and Kahraman A. Outcome and Genetic Factors in IgG4-Associated Autoimmune Pancreatitis and Cholangitis: A Single Center Experience. Gastroenterol Res Pract. 2017;2017:6126707. doi: 10.1155/2017/6126707. Epub 2017 Mar 2 1.7
   
8. EV-TRACK Consortium, Van Deun J, Mestdagh P, [...], Bremer M, [...], Giebel B, [...] & Hendrix A. EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research. Nature Methods. 2017 Feb; 14:228–32 25.3
   
9. O'Driscoll L, Stoorvogel W, Théry C, Buzas E, Nazarenko I, Siljander P, Yáñez-Mó M, Fais S, Giebel B, Yliperttula M. European Network on Microvesicles and Exosomes in Health and Disease (ME-HaD). Eur J Pharm Sci. 2017 Feb 15;98:1-3 3.8
   
10. Kordelas L, Buttkereit U, Lindemann M, Koldehoff M, Klisanin V, Horn PA, Fleischhauer K, Dietrich W. Beelen DW. αβ-T-cell depleted donor lymphocyte infusion for leukemia relapse after allogeneic stem cell transplantation. Bone Marrow Transplant 2017 Sep 4. doi: 10.1038/bmt.2017.185. [Epub ahead of print] 3.9
   
11. Jiqiaoa Z, Yenga Z, Dolff S, Bienholz A, Lindemann M, Brinkhoff A, Schedlowski M, Xua S, Suna M, Guberina H, Kirchhof J, Kribben A, Witzke O, Wilde B (2017): Granzyme B producing B-cells in renal transplant patients. Clin Immunol. Apr 28. [Epub ahead of print]. 4.0
   
12. Lindemann M, Zaslavskaya M, Fiedler M, Wilde B, Heinemann FM, Heinold A, Horn PA, Witzke O. Humoral and cellular responses to a single dose of Fendrix in renal transplant recipients with non-response to previous hepatitis B vaccination. Scand J Immunol. 2017 Jan;85(1):51-7 2.3
   
13. Barsegian V, Müller SP, Möckel D, Horn PA, Bockisch A, Lindemann M. Lymphocyte function following radium-223 therapy in patients with metastasized, castration resistant prostate cancer. Eur J Nucl Med Mol Imaging. 2017 Feb;44(2):242-6. 7.2
   
14. Reiner AT, Witwer KW, van Balkom BWM, de Beer J, Brodie C, Corteling RL, Gabrielsson S, Gimona M, Ibrahim AG, de Kleijn D, Lai CP, Lötvall J, Del Portillo HA, Reischl IG, Riazifar M, Salomon C, Tahara H, Toh WS, Wauben MHM, Yang VK, Yang Y, Yeo RWY, Yin H, Giebel B, Rohde E, Lim SK. Concise Review: Developing Best-Practice Models for the Therapeutic Use of Extracellular Vesicles. Stem Cells Transl Med. 2017 Aug;6(8):1730-9 4.2
   
15. Börger V, Bremer M, Ferrer-Tur R, Gockeln L, Stambouli O, Becic A, Giebel B. Mesenchymal Stem/Stromal Cell-Derived Extracellular Vesicles and Their Potential as Novel Immunomodulatory Therapeutic Agents. Int J Mol Sci. 2017 Jul 6;18(7). 3.2
   
16. Kraemer M, Becker J, Horn PA, Schwitalla JC, Keyvani K, Metz I, Wegner C, Brück W, Schlamann M, Heinemann FM*, Berlit P*. Association of primary central nervous system vasculitis with the presence of specific human leucocyte antigen gene variant. Clin Neurol Neurosurg. 2017 Sep;160:137-141. doi: 10.1016/j.clineuro.2017.06.009. Epub 2017 Jun 23. 1.4
   
17. Ahci M, Stempelmann K, Buttkereit U, Crivello P, Trilling M, Heinold A, Steckel NK, Koldehoff M, Horn PA, Beelen DW, Fleischhauer K. Clinical Utility of Quantitative PCR for Chimerism and Engraftment Monitoring after Allogeneic Stem Cell Transplantation for Hematologic Malignancies. Biol Blood Marrow Transplant. 2017 Oct;23(10):1658-1668. doi: 10.1016/j.bbmt.2017.05.031. Epub 2017 Jun 8. 4.7
   
18. Giebel B, Helmbrecht C. Methods to Analyze EVs. Methods Mol Biol. 2017;1545:1-20.  
   
2016 Impact Faktor
1. Drommelschmidt K, Serdar M, Bendix I, Herz J, Bertling F, Prager S, Keller M, Ludwig AK, Duhan V, Radtke S, de Miroschedji K, Horn PA, van de Looij Y, Giebel B, Felderhoff-Müser U. Mesenchymal stem cell-derived extracellular vesicles ameliorate inflammation-induced preterm brain injury. Brain Behav Immun. 2017;60:220-32  
   
2. Lindemann M, Lenz V, Nyadu B, Heinemann FM, Heinold A, Guberina H, Eisenberger U, Lachmann N, Schönemann C, Kribben A, Paul A, Horn PA, Witzke O. Effect of ABO incompatibility on T cell flow cytometry crossmatch results prior to living donor kidney transplantation. Cytometry B Clin Cytom. 2016 Nov 18. doi: 10.1002/cyto.b.21496. [Epub ahead of print] 2.8
   
3. Guberina H, Rebmann V, Wagner B, da Silva Nardi F, Dziallas P, Dolff S, Bienholz A, Wohlschlaeger J, Bankfalvi A, Heinemann FM, Witzke O, Zoet YM, Claas FHJ, Horn PA, Kribben A, Doxiadis IIN. Association of high HLA-E expression during acute cellular rejection and numbers of HLA class I leader peptide mismatches with reduced renal allograft survival. Immunobiology. 2016 Nov [in press]  
   
4. Wagner B, da Silva Nardi F, Schramm S, Kraemer T, Celik AA, Dürig J, Horn PA, Dührsen U, Nückel H, Rebmann V. HLA-E allelic genotype correlates with HLA-E plasma levels and predicts early progression in chronic lymphocytic leukemia. Cancer. 2016 Nov. [Epub ahead of print]  
   
5. Kordelas L, Steckel NK, Horn PA, Beelen DW, Rebmann V. The Activating NKG2C Receptor Is Significantly Reduced in NK Cells after Allogeneic Stem Cell Transplantation in Patients with Severe Graft-versus-Host Disease. Int J Mol Sci. 2016 Oct; 17(11)  
   
6. Luckau S, Wehrs TP, Brandau S, Horn PA, Lindemann M. Vaccination against human papilloma viruses leads to a favorable cytokine profile of specific T cells. J Immunother. 2016; 39(8), 316-320. 3.7
   
7. Stanurova J, Neureiter A, Hiber M, de Oliveira Kessler H, Stolp K, Goetzke R, Klein D, Bankfalvi A, Klump H, Steenpass L. Angelman syndrome-derived neurons display late onset of paternal UBE3A silencing. Nature Scientific Reports. 2016 Aug; 6: 30792 5.5
   
8. Nardi Fda S, König L, Wagner B, Giebel B, Santos Manvailer LF, Rebmann V. Soluble monomers, dimers and HLA-G-expressing extracellular vesicles: the three dimensions of structural complexity to use HLA-G as a clinical biomarker. HLA. 2016 Sep; 88(3):77-86  
   
9. Rashidi-Alavijeh J, Heinold A, Willuweit K, Baba HA, Horn PA, Paul A, Witzke O, Gerken G, Herzer K. Diagnostics and treatment of a severe humoral rejection after liver transplantation: donor-specific antibodies as a still underestimated cause of graft failure. Z Gastroenterol. 2016 Jul; 54(7):647-52  
   
10. Mertens A, Brandl C, Miron-Shatz T, Schlick C, Neumann T, Kribben A, Meister S, Jonas Diamantidis C, Albrecht UV, Horn PA, Becker S. A mobile application improves therapy-adherence rates in elderly patients undergoing rehabilitation: A crossover design study comparing documentation via iPad with paper-based control. Medicine (Baltimore). 2016 Sep; 95(36):e4446.  
   
11. Zhao F, Lübcke S, Sucker A, Fatho M, Horn S, Heeke C, Bielefeld N, Lindemann M, Stiller M, Becker JC, Lennerz V, Schadendorf D, Griewank K, Wölfel T, Paschen A. Melanoma lesions independently acquire T-cell resistance during metastatic latency. Cancer Res. 2016; 76(15):4347-58 9.3
   
12. Goergens A. Analysis of extracellular vesicles including exosomes by imaging flow cytometry. Science Webinar Series. Science 2016; 352(6290):1238  
   
13. Görgens A, Murke F, Kordelas L, Giebel B. Lost in Transplantation? Unexpected shift from multipotent to late lymphomyeloid hematopoietic stem and progenitor cells in patients 1 year after hematopoietic stem cell transplantation. Bone Marrow Transplant. 2016 Aug; 51(8):1073-5 3.6
   
14. Botezatu L, Michel LC, Helness A, Vadnais C, Hönes JM, Makishima H, Robert F, Vassen L, Aniththa Thivakaran1, Al-Matary Y, Lams RF, Schütte J, Giebel B, Görgens A, Heuser M, Medyouf H, Maciejewski J, Dührsen U, Möröy T,Khandanpour C. Epigenetic therapy as a novel approach for GFI136N-associated murine/human AML. Exp. Hematol. 2016; 44(8):713-26 2.5
   
15. Huetter FK, Bachmann HS, Reinders A, Siffert D, Stelmach P, Knop D, Horn PA, Siffert W. Association of a Common Oxytocin Receptor Gene Polymorphism with Self-Reported 'Empathic Concern' in a Large Population of Healthy Volunteers. PLoS One. 2016 Jul; 11 (7): e0160059  
   
16. Nardi F da S, Michelon TF, Neumann J, Manvailer LF, Wagner B, Horn PA, Bicalho Mda G, Rebmann V. High levels of circulating extracellular vesicles with altered expression and function during pregnancy. Immunobiology. 2016 Jul; 221(7): 753-60 2.8
   
17. Crivello P, Heinold A, Rebmann V, Ottinger HD, Horn PA, Beelen DW, Fleischhauer K. Functional distance between recipient and donor HLA-DPB1 determines non-permissive mismatches in unrelated HCT. Blood. 2016 Jul 7; 128(1): 120-9 11.8
   
18. Rebmann V, König L, da Silva Nardi F, Wagner B, dos Santos Manvailer LF and Horn PA. The Potential of HLA-G-Bearing Extracellular Vesicles as a Future Element in HLA-G Immune Biology. Front. Immunol., 04 May 2016 5.7
   
19. Ophelders DRMG, Wolfs TGAM, Jellema RK, Zwanenburg A, Andriessen P, Delhaas T, Ludwig AK, Radtke S, Peters V, Janssen L, Giebel B and Kramer BW. Mesenchymal Stromal Cell-Derived Extracellular Vesicles Protect the Fetal Brain After Hypoxia-Ischemia. Stem Cells Transl Med. 2016 Jun; 5(6): 754-63 5.7
   
20. Hombach AA, Görgens A, Chmielewski M, Murke F, Kimpel J, Giebel B, Abken H. Superior therapeutic index in lymphoma therapy: CD30+ CD34+ hematopoietic stem cells resist a chimeric antigen receptor (CAR) T cell attack. Mol Ther. 2016 Aug; 24(8): 1423-34 6.2
   
21. Nel I, Gauler TC, Bublitz K, Lazaridis L, Goergens A, Giebel B, Schuler M, Hoffmann AC. Circulating Tumor Cell Composition in Renal Cell Carcinoma. PLoS One. 2016; 11 (4): e0153018 3.5
   
22. Radtke S, Haworth KG, Kiem HP. The frequency of multipotent CD133+CD45RA−CD34+ hematopoietic stem cells is not increased in fetal liver compared with adult stem cell sources. Exp. Hematology. 2016; 44(6): 502-7 2.5
   
23. Lindemann M, Könemann J, Horn PA, Witzke O. IL-17 ELISpot as Predictor for Kidney Allograft Rejection? Clin Lab. 2016; 62(5): 963-5 1.1
   
24. Fais S, O’Driscoll L, Borras FE, Buzas E, Camussi G, Cappello F, Carvalho J, Cordeiro da Silva A, Del Portillo H, El Andaloussi S, Ficko Trček T, Furlan R, Hendrix A, Gursel I, Kralj-Iglic V, Kaeffer B, Kosanovic M, Lekka ME, Lipps G, Logozzi M, Marcilla A, Sammar M, Llorente A, Nazarenko I, Oliveira C, Pocsfalvi G, Rajendran L, Raposo G, Rohde E, Siljander P, van Niel G, Vasconcelos MH, Yáñez-Mó M, Yliperttula ML, Zarovni N, Zavec AB and Giebel B. Evidence-Based Clinical Use of Nanoscale Extracellular Vesicles in Nanomedicine. ACS Nano. 2016 12.9
   
25. Lindemann M, Koldehoff M, Fiedler M, Schumann A, Ottinger HD, Heinemann FM, Roggendorf M, Horn PA, Beelen DW.Control of hepatitis B virus infection in hematopoietic stem cell recipients after receiving grafts from vaccinated donors. Bone Marrow Transplant. 2016; 51 (3): 428-31 3.6
   
26. Nalivaiko K, Hofmann M, Kober K, Teichweyde N, Krammer PH, Rammensee HG, Grosse-Hovest L, Jung G. A Recombinant Bispecific CD20×CD95 Antibody With Superior Activity Against Normal and Malignant B-cells. Mol Ther. 2016; 24 (2): 298-305 6.2
   
27. Hönes JM, Botezatu L, Helness A, Vadnais C, Vassen L, Robert F, Hergenhan SM, Thivakaran A, Schütte J, Al-Matary YS, Lams RF, Fraszscak J, Makishima H, Radivoyevitch T, Przychodzen B, da Conceição Castro SV, Görgens A, Giebel B, Klein-Hitpass L, Lennartz K, Heuser M, Thiede C, Ehninger G, Dührsen U, Maciejewski J, Möröy T, Khandanpour C. GFI1 as a novel prognostic and therapeutic factor for AML/MDS. Leukemia. 2016 Feb 5. doi: 10.1038/leu.2016.11. 10.4
   
28. Nardi FS, Slowik R, Michelon TF, Manvailer LFS, Wagner B, Neumann JM, Horn PA, Bicalho MG, Rebmann V. High amounts of total and extracellular vesicle-derived soluble HLA-G are associated with HLA-G 14bp deletion variant in embryo implantation failure women. Am J Reprod Immunol. 2016 Jun; 75(6): 661-71 2.4
   
29. Wnuck Lipinski K, Sattler K, Peters S, Weske S, Keul P, Klump H, Heusch G, Göthert JR, Levkau B. Hepatocyte Nuclear Factor 1A Is a Cell-Intrinsic Transcription Factor Required for B Cell Differentiation and Development in Mice. J Immunol. 2016 Feb 15; 196(4): 1655-65 4.9
   
30. Zeuner MT, Patel K, Denecke B, Giebel B, Widera D. Paracrine effects of TLR4-polarised mesenchymal stromal cells are mediated by extracellular vesicles. J Transl Med. 2016 Feb. 3.9
   
31. Börger V, Bremer M, Görgens A, Giebel B. Mesenchymal stem/stromal cell-derived extracellular vesicles as a new approach in stem cell therapy. ISBT Sci Ser. 2016; 11 (1): 228–234  
   
32. Engert A, Balduini C, Brand A, Coiffier B, Cordonnier C, Döhner H, de Wit TD, Eichinger S, Fibbe W, Green T, de Haas F, Iolascon A, Jaffredo T, Rodeghiero F, Salles G, Schuringa JJ, […], Klump H, […], Zieger B. The European Hematology Association Roadmap for European Hematology Research: a consensus document. Haematologica. 2016; 101(2): 115-208. 6.7
   
33. Radtke S, Görgens A, Liu B, Horn PA & Giebel B. Human mesenchymal and murine stromal cells support human lympho-myeloid progenitor expansion but not maintenance of multipotent haematopoietic stem and progenitors cells. Cell Cycle. 2016 Feb 16; 15(4): 540-5 5.0
   
34. König L, Kasimir-Bauer S, Hoffmann O, Bittner AK, Wagner B, Manvailer LF, Schramm S, Bankfalvi A, Giebel B, Kimmig R, Horn PA, Rebmann V. The prognostic impact of soluble and vesicular HLA-G and its relationship to circulating tumor cells in neoadjuvant treated breast cancer patients. Hum Immunol. 2016; 77(9):791–99 2.3
2015 Impact Factor
1. Lener T, Gimona M, Ludwig Aigner L, Börger V, [...], Görgens A, [...], Horn PA, [...], Rohde E, Giebel B. Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper. J Extracell Vesicles. 2015; 4: 30087  
   
2. Denecke B, Horsch LD, Radtke S, Fischer JC, Horn PA, Giebel B. Human endothelial colony-forming cells expanded with an improved protocol are a useful endothelial cell source for scaffold-based tissue engineering.J Tissue Eng Regen Med. 2015; 9 (11): E84-97 5.2
   
3. Murke F, Castro SVC, Giebel B, Görgens A. Concise Review: Asymmetric Cell Divisions in Stem Cell Biology. Symmetry. 2015; 7: 2025-2037 0.8
   
4. Schumann A, Fiedler M, Beckebaum S, Cicinnati VR, Herzer K, Lenz V, Witzke O, Paul A, Roggendorf M, Horn PA, Lindemann M. Donor- and recipient-derived immunity in ABO incompatible living-related liver transplantation. Hum Immunol. 2015; 76: 631-635 2.1
   
5. Loeffek S, Ullrich N, Görgens A, Murke F, Eilebrecht M, Menne C, Giebel B, Schadendorf D, Singer BB, Helfrich I. CEACAM1-4L promotes anchorage-independent growth in melanoma. Front Oncol. 2015; 5: 234  
   
6. Süsal C, Seidl C, Schönemann C, Heinemann FM, Kauke T, Gombos P, Arns W, Bauerfeind U, Hallensleben M, Einecke G, Hauser I, Kelsch K, Blasczyk R. Determination of unacceptable HLA antigen mismatches in kidney transplant recipients: recommendations of the German Society for Immunogenetics. Tissue Antigens. 2015 Nov; 86 (5): 317-23 2.1
   
7. Görgens A, Horn PA. From Basic Biology to Engineering and Clinical Translation of Stem Cells. Cellular Reprogramming. December 2015; 17 (6): 415-418 1.8
   
8. Börger V, Görgens A, Rohde E, Giebel B. Therapeutisches Potenzial von extrazellulären Vesikeln aus mesenchymalen Stamm- bzw. Stromazellen. Transfusionsmedizin. 2015; 5: 131–137  
   
9. Doeppner TR, Herz J, Görgens A, Schlechter J, Ludwig AK, Radtke S, de Miroschedji K, Horn PA, Giebel B and Hermann DM. Extracellular vesicles improve post-stroke neuroregeneration and prevent post-ischemic immunosuppression. Stem Cells Transl Med. 2015; 4 (10): 1131-43 5.7
   
10. Görgens A, Giebel B. Wie unser Blut entsteht – neue Erkenntnisse zur Hämatopoese. BIOspektrum. 2015; 21 (3): 290-293  
   
11. Yáñez-Mó M, Siljander PRM, Andreu Z, [...], Giebel B, [...], Vasconcelos MH, Wauben MHM, De Wever O. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015; 4: 27066  
   
12. Graffmann N, Brands J, Görgens A, Vitoriano da Conceição Castro S, Santourlidis S, Reckert A, Michele I, Ritz-Timme S, Fischer JC, Adjaye J, Kögler G, Giebel B, Uhrberg M. Age-related increase of EED expression in early hematopoietic progenitor cells is associated with global increase of the histone modification H3K27me3. Stem Cells Dev. 2015 Sep 1; 24(17): 2018-31 4.2
   
13. LeMaoult J, Caumartin J, Daouya M, Switala M, Rebmann V, Arnulf B, Carosella ED. Trogocytic intercellular membrane exchanges among hematological tumors. J HEMATOL ONCOL. 2015; 8: 24 4.9
   
14. Barsegian V, Hueben C, Mueller SP, Poeppel TD, Horn PA, Bockisch A, Lindemann M. Impairment of lymphocyte function following yttrium-90 DOTATOC therapy. Cancer Immunol Immunother. 2015; 64 (6): 755-64 3.9
   
15. Koldehoff M, Lindemann M, Opalka B, Bauer S, Ross RS, Elmaagacli AH. Cytomegalovirus induces apoptosis in acute leukemia cells as a virus-versus-leukemia function. Leuk Lymphoma. 2015; 56(11): 3189-3197 2.6
   
16. Radtke S, Görgens A, Kordelas L, Schmidt M, Kimmig KR, Köninger A, Horn PA, Giebel B. CD133 allows elaborated discrimination and quantification of haematopoietic progenitor subsets in human haematopoietic stem cell transplants. Br. J. Haematol. 2015; 169 (6):868-78 5.0
   
17. T.D. Veit, J.A. Bogo Chies, M. Switala, B. Wagner, P.A. Horn, M. Busatto, C. Viegas Brenol, JC. Tavares Brenol, R. Machado Xavier, V. Rebmann. The paradox of high availability and low recognition of soluble HLA-G by LILRB1 receptor in rheumatoid arthritis patients. PLOS ONE 2015; 10 (4): e0123838 3.5
   
18. Kefalakes H, Budeus B, Walker A, Jochum C, Hilgard G, Heinold A, Heinemann FM, Gerken G, Hoffmann D, Timm J. Adaption of hepatitis B virus core protein to CD8+ T cell selection pressure. Hepatology. 2015; 62 (1): 47-56 11.2
   
19. Schukfeh N, Lenz V, Metzelder M, Paul A, Mathe Z, Kathemann S, Hoyer PF, Dohna-Schwake C, Gerner P. First Case Studies of Successful ABO-Incompatible Living-Related Liver Transplantation in Infants in Germany. Eur J Pediatr Surg. 2015 Feb; 25(1): 77-81 1.0
   
20. Kefalakes H, Jochum C, Hilgard G, Kahraman A, Bohrer AM, El Hindy N, Heinemann FM, Gerken G, Roggendorf M, Timm J. Decades after recovery from hepatitis B and HBsAg clearance the CD8+ T cell response against HBV core is nearly undetectable. J Hepatol. 2015; 63 (1): 13-9 10.4
   
21. Seifert M, Przekopowitz M, Sarah Taudien S, Lollies A, Ronge V, Drees B, Lindemann M, Hillen U, Engler H, Singer BB, Kueppers R (2014): Functional capacities of human IgM memory B cells in early inflammatory responses and secondary germinal center reactions. Proc Natl Acad Sci USA. 2015; 112(6): E546-55 9.8
   
22. Krawczyk A, Dirks M, Kasper M, Buch A, Dittmer U, Giebel B, Wildschütz L, Busch M, Goergens A, Schneweis KE, Eis-Hübinger AM, Sodeik B, Heiligenhaus A, Roggendorf M, Bauer D. Prevention of Herpes Simplex Virus Induced Stromal Keratitis by a Glycoprotein B-Specific Monoclonal Antibody PLoS ONE. 2015; 10(1): e0116800 3.5
   
23. Iacob S, Cicinnati VR, Heinemann FM, Lindemann M, Radtke A, Kaiser G, Kabar I, Schmidt HHJ, Baba HA, Beckebaum S. Donor specific anti-HLA antibodies and endothelial C4d deposition - association with chronic liver allograft failure.Transplantation. 2015 Sep; 99(9): 1869-75 3.5
   
24. Albring A, Wendt L, Harz N, Engler H, Wilde B, Kribben A, Lindemann M, Schedlowski M, Witzke O. Relationship between pharmacokinetics and pharmacodynamics of calcineurin inhibitors in renal transplant patients. Clin Transplant. 2015; 29(4): 294-300 1.5
2014  
1. Radtke, S., Giebel, B., Wagner, W., and Horn, P.A. Platelet lysates and their role in cell therapy. ISBT Science Series. 2014; 9(1): 193-7  
   
2. Brandau S, Jakob M, Bruderek K, Bootz F, Giebel B, Radtke S, Mauel K, Jäger M, Flohé SB, Lang S. Mesenchymal stem cells augment the anti-bacterial activity of neutrophil granulocytes. PLoS One. 2014; 9(11): e114201 3.5
   
3. Müller CR, Mytilineos J, Ottinger H, Arnold R, Bader P, Beelen D, Bornhäuser M, Dreger P, Eiermann T, Einsele H, Faé I, Fischer G, Füssel M, Holler E, Holzberger G, Horn PA, Kröger N, Lindemann M, Seidl C, Spriewald B, Süsal C, Blasczyk R, Finke J. Deutscher Konsensus 2013 zur immungenetischen Spenderauswahl für die allogene Stammzelltransplantation. Transfusionsmedizin. 2014; 4: 190-6  
   
4. Riebschläger S. Vom Suchen und Finden - 25 Jahre nicht verwandte Blutstammzellspendersuche am Universitätsklinikum Essen Transfusionsmedizin. 2014; 4: 187-9  
   
5. Kim DK, Lee J, Kim SR, Choi DS, Yoon YJ, [...], Giebel B, [...], Zeidler R, Gho YS. EVpedia: A Community Web Portal for Extracellular Vesicles Research. Bioinformatics. 2014; 31 (6): 933-9 4.6
   
6. Sucker A, Zhao F, Real B, Heeke C, Bielefeld N, Massen S, Horn S, Moll I, Maltaner R, Horn PA, Schilling B, Sabbatino F, Lennerz V, Kloor M, Ferrone S, Schadendorf D, Falk CS, Griewank K, Paschen A. Genetic evolution of T-cell resistance in the course of melanoma progression. Clin Cancer Res. 2014; 20(24): 6593-604 8.2
   
7. Rebmann V, da Silva Nardi F, Wagner B, Horn PA. HLA-G as a tolerogenic molecule in transplantation and pregnancy. J Immunol Res. 2014; 2014: 297073 2.9
   
8. Görgens A, Ludwig AK, Möllmann M, Krawczyk A, Dürig J, Hanenberg H, Horn PA, Giebel B. Multipotent hematopoietic progenitors divide asymmetrically to create progenitors of the Lympho-Myeloid and Erythro-Myeloid Lineages. Stem Cell Reports. 2014; 3(6): 1058-72 5.4
   
9. Lindemann M. Ex vivo assessment of cellular immune function – applications in patient care and clinical studies. Tissue Antigens. 2014; 84(5): 439-49 2.8
   
10. Ziegler S, Skibbe K, Walker A, Ke X, Heinemann FM, Heinold A, Mok JY, van Esch WJE, Yang D, Wölfl M, Timm J. Impact of sequence variation in a dominant HLA-A*02-restricted epitope in HCV on priming and cross-reactivity of CD8+ T cells. J Virol. 2014; 88(19): 11080-90 5.1
   
11. Krawczyk A, Ludwig C, Jochum C, Fiedler M, Heinemann FM, Shouval D, Roggendorf M, Roggendorf H, Lindemann M. Induction of a robust T- and B-cell immune response in non- and low-responders to conventional vaccination against hepatitis B by using a third generation PreS/S vaccine. Vaccine. 2014; 32(39): 5077-82 3.5
   
12. Malyar NM, Radtke S, Malyar K, Arjumand J, Horn PA, Kröger K, Freisinger E, Reinecke H, Giebel B, Brock FE. Autologous Bone Marrow Mononuclear Cell Therapy Improves Symptoms in Patients with End-Stage Peripheral Arterial Disease and Reduces Inflammation Associated Parameters. Cytotherapy. 2014; 16(9): 1270-9 3.3
   
13. Thoens C, Berger C, Trippler M, Siemann H, Lutterbeck M, Broering R, Schlaak J, Heinemann FM, Heinold A, Nattermann J, Scherbaum N, Alter G, Timm J. KIR2DL3+NKG2A- Natural Killer Cells are Associated with Protection from Productive Hepatitis C Virus Infection in People who Inject Drugs. J Hepatol. 2014; 61(3): 475-81 9.9
   
14. Kordelas L, Verheyen J, Beelen DW, Horn PA, Heinold A, Kaiser R, Trenschel R , Schadendorf D, Dittmer U, Esser S. Shift of HIV Tropism in Stem-Cell Transplantation with CCR5 Delta32 Mutation. N Engl J Med. 2014; 371(9): 880-2 54.4
   
15. Valencia K, Luis-Ravelo D, Bovy N, Antón I, Martínez-Canarias S, Zandueta C, Ormazábal C, Struman I, Tabruyn S, Rebmann V, De Las Rivas J, Guruceaga E, Bandrés E, Lecanda F. miRNA cargo within exosome-like vesicle transfer influences metastatic bone colonization. Mol Oncol. 2014; 8(3): 689-703 6.7
   
16. Trettner S, Findeisen A, Taube S, Horn PA, Sasaki E, Zur Nieden NI. Osteogenic induction from marmoset embryonic stem cells cultured in feeder-dependent and feeder-independent conditions. Osteoporos Int. 2014; 25(4): 1255-66 4.0
   
17. Kordelas L, Rebmann V, Ludwig AK, Radtke S, Ruesing J, Doeppner TR, Epple M, Horn PA, Beelen DW, Giebel B. MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease. Leukemia. 2014; 28(4): 970-3 10.2
   
18. Hemeda H, Giebel B, Wagner W. Evaluation of human platelet lysate versus fetal bovine serum for culture of mesenchymal stromal cells. Cytotherapy. 2014; 16(2): 170-80 3.3
   
2013  
1. Guberina H, Heinemann F, Heinold A, Lindemann M, Eisenberger U, Horn PA, Witzke O (2013): Blutgruppeninkompatible Lebendnierentransplantation einer Patientin mit Spender-spezifischen Antikörpern. Transfusionsmedizin 3, 191-195.  
   
2. Martelli-Palomino G, Pancotto JA, Muniz YC, Mendes-Junior CT, Castelli EC, Massaro JD, Krawice-Radanne I, Poras I, Rebmann V, Carosella ED, Rouas-Freiss N, Moreau P, Donadi EA. Polymorphic Sites at the 3’ Untranslated Region of the HLA-G Gene Are Associated with Differential HLA-G Soluble Levels in the Brazilian and French Population. PLoS One. 2013; 8(10): e71742 3.7
   
3. Görgens A, Radtke S, Horn PA, Giebel B. New Relationships of Human Hematopoietic Lineages Facilitate Detection of Multipotent Hematopoietic Stem and Progenitor Cells. Cell Cycle. 2013; 12(22): 3478-82 5.2
   
4. Krawczyk A, Roggendorf H, Ludwig C, Herzer K, Gerken G, Horn PA, Roggendorf M, Lindemann M. Therapeutic vaccination of a liver transplant recipient suffering from fulminant hepatitis B during pregnancy. Liver Transpl. 2013; 19(12): 141-2 3.9
   
5. Lindemann M, Heinemann FM, Heinold A, Zaslavskaya M, Horn PA, Witzke O. Pneumococcal antibodies in kidney transplant recipients are predictive of patient survival. Scand J Immunol. 2013; 78(6): 554-6 2.2
   
6. Radtke S, Horn PA. Pluripotent and Somatic Stem Cells: From Basic Science to Utilization in Disease Modeling and Therapeutic Application. Cell Reprogram. 2013; (5): 394-6 2.7
   
7. Muturi HT, Dreesen, JD, Nilweski E, Jastrow H, Giebel B, Ergun S, Singer BB. Tumor and Endothelial Cell-Derived Microvesicles Carry Distinct CEACAMs and Influence T-Cell Behavior. PLOS One. 2013; 8(9): e74654 3.7
   
8. Figueiredo C, Wedekind D, Mueller T, Vahlsing S, Horn PA, Seltsam A, Blasczyk R. MHC universal cells survive in an allogeneic environment after incompatible transplantation. BioMed Research International. 2013; Article ID 796046. doi: 10.1155/2013/796046 2.9
   
9. Lindemann M, Heinemann FM, Horn PA, Witzke O. Vaccination against Streptococcus pneumoniae does not induce antibodies against HLA or MICA in clinically stable kidney transplant recipients. Hum Immunol. 2013; 74(10): 1267-70 2.3
   
10. Pajtler KW, Rebmann V, Lindemann M, Schulte JH, Schulte S, Stauder M, Leuschner I, Schmid KW, Köhl U, Schramm A, Eggert A. Expression of NTRK1/TrkA affects immunogenicity of neuroblastoma cells. Int J Cancer. 2013; 133(4): 908-19 5.4
   
11. Bröcker V, Pfaffenbach A, Habicht A, Chatzikyrkou C, Kreipe HH, Haller H, Scheffner I, Gwinner W, Zilian E, Immenschuh S, Schwarz A, Horn PA, Heinemann FM, Becker JU. Beyond C4d: The ultrastructural appearances of endothelium in ABO-incompatible renal allografts. Nephrol Dial Transplant. 2013; (12): 3101-9 3.4
   
12. Heinrichs S, Conover LF, Bueso-Ramos CE, Kilpivaara O, Stevenson K, Neuberg D, Loh ML, Wu WS, Rodig SJ, Garcia-Manero G, Kantarjian HM, Look AT. MYBL2 is a sub-haploinsufficient tumor suppressor gene in myeloid malignancy. Elife. 2013; 2: e00825 8.5
   
13. Pilat S, Carotta S, Klump H. Development of Hematopoietic Stem and Progenitor Cells from Mouse Embryonic Stem Cells, In Vitro, Supported by Ectopic Human HOXB4 Expression. Methods Mol Biol. 2013; 1029: 129-47  
   
14. Görgens A, Radtke S, Moellmann M, Cross M, Duerig J, Horn PA, Giebel B. Revision of the Human Hematopoietic Tree: Granulocyte Subtypes Derive from Distinct Hematopoietic Lineages. Cell Reports. 2013; 3(5): 1539-52 8.4
   
15. Klump H, Teichweyde N, Hinrichs C, Horn PA. Development of patient-specific hematopoietic stem and progenitor cell grafts from pluripotent stem cells, in vitro. Curr Mol Med. 2013; 13(5): 815-20 5.1
   
16. Agustian PA, Bockmeyer CL, Modde F, Wittig J, Heinemann FM, Brundiers S, Dämmrich ME, Schwarz A, Birschmann I, Suwelack B, Jindra PT, Ahlenstiel T, Wohlschläger J, Vester U, Ganzenmüller T, Zilian E, Feldkamp T, Spieker T, Immenschuh S, Kreipe HH, Bröcker V, Becker JU. Glomerular mRNA Expression of Prothrombotic and Antithrombotic Factors in Renal Transplants With Thrombotic Microangiopathy. Transplantation. 2013; 95(10): 1242-8 4.0
   
17. Krawczyk A, Arndt MAE, Grosse-Hovestc L, Weichert W, Giebel B, Dittmer U, Hengel H, Jäger D, Schneweis KE, Eis-Hübingerg AM, Roggendorf M, Krauss J. Overcoming drug-resistant herpes simplex virus (HSV) infection by a humanized antibody. Proc Natl Acad Sci USA. 2013; 110(17): 6760-5 9.7
   
18. Alegre E, Rebmann V, Lemaoult J, Rodriguez C, Horn PA, Díaz-Lagares A, Echeveste JI, González A. In vivo identification of an HLA-G complex as ubiquitinated protein circulating in exosomes. Eur J Immunol. 2013; 43(7): 1933-9 5.1
   
19. Schilling B, Sucker A, Griewank K, Zhao F, Weide B, Görgens A, Giebel B, Schadendorf D, Paschen A. Vemurafenib reverses immunosuppression by myeloid derived suppressor cells. Int J Cancer. 2013; 133(7): 1653-63 5.4
   
20. Ziegler S, Ruhl M, Tenckhoff H, Wiese M, Heinemann FM, Horn PA, Spengler U, Neumann-Haefelin C, Nattermann J, Timm J.East-German HCV Study Group. Susceptibility to chronic hepatitis C virus infection is influenced by sequence differences in immunodominant CD8+ T cell epitopes. J Hepatol. 2013; 58(1): 24-30 9.3
   
21. Arnold ML, Heinemann FM, Horn P, Ziemann M, Lachmann N, Mühlbacher A, Dick A, Ender A, Thammanichanond D, Fischer GF, Schaub S, Hallensleben M, Mytilineos J, Hitzler WE, Seidl C, Doxiadis II, Spriewald BM. Anti-HLA alloantibodies of the of IgA isotype in re-transplant candidates. Int J Immunogenet. 2013; 40(1): 17-20 2.9
   
22. Heinold A, Opelz G, Döhler B, Unterrainer C, Scherer S, Ruhenstroth A, Tran TH. Deleterious Impact of HLA-DRB1 Allele Mismatch in Sensitized Recipients of Kidney Retransplants. Transplantation. 2013; 95(1): 137-41 4.0
   
23. Adamek M, Heyder J, Heinold A, Fiedler G, Opelz G, Tran TH. Characterization of mannose-binding lectin (MBL) variants by allele-specific sequencing of MBL2 and determination of serum MBL protein levels. Tissue Antigens. 2013; 82(6): 410-415 2.8
   
2012    
1. Trobridge G, Horn PA, Beard B, Kiem HP. Large Animal Models for Foamy Virus Vector Gene Therapy. Viruses. 2012; 4: 3572-88 1.5  
     
2. Lesinski DA, Heinz N, Pilat-Carotta, S, Rudolph C, Jacobs R, Schlegelberger B, Klump H*, Schiedlmeier B. Serum- and stromal cell-free generation of embryonic stem cell-derived hematopoietic cells, in vitro, capable of multilineage repopulation of immunocompetent mice. Stem Cells Transl Med. 2012; 581-91 (*co-correspondence). 3.6  
     
3. Bellucci R, Nguyen HN, Martin A, Heinrichs S, Schinzel AC, Hahn, WC, Ritz J. Tyrosine kinase pathways modulate tumor susceptibility to natural killer cells. J Clin Invest. 2012; 122(7): 2369–83 13.1  
     
4. Sallmon H, Weber SC, Hüning B, Stein A, Horn PA, Metze BC, Dame C, Bührer C, Felderhoff-Müser U, Hansmann G, Koehne P. Thrombocytopenia in the First 24 Hours After Birth and Incidence of Patent Ductus Arteriosus. Pediatrics. 2012; 130(3): 623-30 5.4  
     
5. Roos M, Baumann M, Liu D, Heinemann FM, Lindemann M, Horn PA, Türk T, Lutz J, Heemann U, Witzke O, von Eynatten M. Low pre-transplant adiponectin multimers are associated with adverse allograft outcomes in kidney transplant recipients a 3-year prospective study. Regul Pept. 2012; 178(1-3): 11-5 2.1  
     
6. Iacob S, Cicinnati VR, Dechêne A, Lindemann M, Heinemann FM, Rebmann V, Ferencik S, Sotiropoulos GC, Popescu I, Horn PA, Gerken G, Paul A, Beckebaum S. Genetic, immunological and clinical risk factors for biliary strictures following liver transplantation. Liver Int. 2012; 32(8): 1253-61 3.8  
     
7. Gortner L, Felderhoff-Müser U, Monz D, Bieback K, Klüter H, Jellema R, Kramer BW, Keller M, Reiss I, Horn PA, Giebel B. Regenerative Therapies in Neonatology: Clinical Perspectives. Klin Padiatr. 2012; 224(4): 233-240 1.6  
     
8. Goergens A, Beckmann J, Ludwig AK, Möllmann M, Dürig J, Horn PA, Rajendrand L, Giebel B. Lipid raft redistribution and morphological cell polarization are separable processes providing a basis for hematopoietic stem and progenitor cell migration. Int J Biochem Cell Biol. 2012; 1121-32 5.0  
     
9. Doeppner TR, Ewert T AS, Tönges L, Herz J, Zechariah A, El-Ali A, Ludwig AK, Giebel B, Nagel F, Dietz PH, Weise J, Hermann DM, Bähr M. Transduction of Neural Precursor Cells with TAT-Hsp70 Chaperone: Therapeutic Potential Against Ischemic Stroke After Intrastriatal and Systemic Transplantation. Stem Cells. 2012; 30(6): 1297-310 7.8  
     
10. Heyder J, Heinold A, Fiedler G, Opelz G, Tran TH. Characterization of four new HLA alleles: HLA-B*15:01:18, HLA-B*44:110, HLA-C*04:01:22 and HLA-DQB 1*05:14. Tissue Antigens. 2012; 79(3): 209-10 3.0  
     
11. González A, Rebmann V, LeMaoult J, Horn PA, Carosella ED, Alegre E. The immunosuppressive molecule HLA-G and its clinical implications. Crit Rev Clin Lab Sci. 2012; 49(3): 63-84 5.7  
     
12. Giebel B, Wodarz A. Notch Signaling: Numb Makes the Difference. Current Biology. 2012; 22(4): 133-35 10.3  
     
13. Elmaagacli AH, Koldehoff M, Lindemann M, Sonius M, Ditschkowski M, Steckel N, Beelen DW. Response: T cells are required for the CMV-induced antileukemia effect after transplant. Blood. 2012; 119(4): 1090-1 10.6  
     
14. Lindemann M, Heinemann FM, Horn PA, Witzke O: Long-term response to vaccination against pneumococcal antigens in kidney transplant recipients. Transplantation. 2012; 94(1): 1-7 4.0  
     
15. Kraemer M, Horn PA, Roder C, Khan N Diehl RR, Berlit P, Heinemann FM. Analysis of human leucocyte antigen genes in Caucasian patients with idiopathic Moyamoya angiopathy. Acta Neurochirurgica. 2012; 154(3): 445-54 1.3  
     
16. Esser S, Jablonka R, Heinemann FM, Reuter S, Jaeger H, Von Krosigk A, Schenk-Westkamp P, Schadendorf D, Horn PA, Lindemann M. Detection of abacavir hypersensitivity by ELISpot method. Inflamm Allergy Drug Targets. 2012; 11(3): 227-34    
     
17. Vennemann MM, Loddenkötter B, Fracasso T, Mitchell EA, Debertin AS, Larsch KP, Sperhake JP, Brinkmann B, Sauerland C, Lindemann M, Bajanowski T. Cytokines and sudden infant death. Int J Legal Med. 2012; 126(2): 279-84 2.9  
     
18. Kraemer M, Heinemann FM, Horn PA, Venker C, Berlit P, Krischek B, Khan N. Inheritance of moyamoya disease in a Caucasian family. Eur J Neurol. 2012; 438-42 3.8  
     
19. Ludwig AK, Giebel B. EXOSOMES: Small vesicles participating in intercellular communication. Int J Biochem Cell Biol. 2012; 44(1): 11-15 4.9  
     
20. Ruhl M, Chhatwal P, Strathmann H, Kuntzen T, Bankwitz D, Skibbe K, Walker A, Heinemann FM, Horn PA, Allen TM, Hoffmann D, Pietschmann T, Timm J. Escape from a dominant HLA-B*15-restricted CD8+ T cell response against hepatitis C virus requires compensatory mutations outside the epitope. J Virol. 2012; 86(2): 991-1000 5.2  
     
21. Nückel H, Castelli EC, Moreau P, Ochsenfarth C, Horn PA, Rebmann V. Simple Methods for the Detection of HLA-G Variants in Coding and Non-coding Regions. Methods Mol Biol. 2012;882: 123-42    
     
Buchbeiträge    
     
Lindemann M, Horn PA, DW Beelen. Zurück ins Leben – Wie sich das Immunsystem nach einer Blutstammzelltransplantation erholt. In: A. Eggert (Hrsg.): Translationale Krebsforschung – Auf dem Weg zu neuen Therapien. ISBN 978-3-934359-42-0    
     
Lindemann M: Determination of nickel and chromium allergy, sensitization, and toxicity by cellular in vitro methods. In: K.-P. Wilhelm, H. Zhai, H.I. Maibach (Eds.): Dermatotoxicology, 8th edition, S. Karger AG, Basel 2012; 322-34 (eBook ISBN 9781841848570, ISBN 9781841848556)    
     
     
2011              
   
1. Wurm M, Gross B, Sgodda M, Ständker L, Müller T, Forssmann WG, Horn PA, Blasczyk R, Cantz T. Improved lentiviral gene transfer into human embryonic stem cells grown in co-culture with murine feeder and stroma cells. Biol Chem. 2011; 392(10): 887-95 3.6
   
2. Radtke S, Horn PA, Cells, Niche, Fate: Meeting Report on the 6th International Meeting of the Stem Cell Network North Rhine Westphalia. Cell Reprogram. 2011; 13(5): 381-4 2.4
   
3. Barsegian V, Müller SP, Horn PA, Bockisch A, Lindemann M. Lymphocyte function following radioiodine therapy in patients with thyroid carcinoma. Nuclear Medicine. 2011; 50(5): 195-203 1.3
   
4. Ruhl M, Knuschke T, Schewior K, Glavinic L, Neumann-Haefelin C, Chang DI, Klein M, Heinemann FM, Tenckhoff H, Wiese M, Horn PA, Viazov S, Spengler U, Roggendorf M, Scherbaum N, Nattermann J, Hoffmann D, Timm J. CD8(+) T-cell response promotes evolution of hepatitis C virus nonstructural proteins. Gastroenterology. 2011; 140(7): 2064-73 12.9
   
5. Sokolova V, Ludwig AK, Hornung S, Rotan O, Horn PA, Epple M, Giebel B. Characterisation of exosomes derived from human cells by nanoparticle tracking analysis and scanning electron microscopy. Colloids Surf B Biointerfaces. 2011; 87(1): 146-50 2.6
   
6. Roos M, Heinemann FM, Lindemann M, Horn PA, Lutz J, Stock K, Thürmel K, Baumann M, Witzke O, Heemann U. Fetuin-A pretransplant serum levels, kidney allograft function and rejection episodes: A 3-year posttransplantation follow-up. Kidney Blood Press Res. 2011; 34(5): 328-33 1.5
   
7. Elmaagacli AH, Steckel NK, Koldehoff M, Hegerfeldt Y, Trenschel R, Ditschkowski M, Christoph S, Gromke T, Kordelas L, Ottinger HD, Ross RS, Horn PA, Schnittger S, Beelen DW. Early human cytomegalovirus replication after transplant is associated with a decreased relapse-risk: evidence for a putative virus-versus-leukemia effect AML patients. Blood. 2011; 118(5): 1402-12 9.9
   
8. Lindemann M, Saure C, Klinkenbusch H, Valentin-Gamazo C, Horn PA, Cicinnati VR, Beckebaum S, Witzke O. Alloreactivity in recipients prior to and post living kidney and liver transplantation. Scand J Immunol. 2011; 73(4): 344-5 2.2
   
9. Verloes A, Van de Velde H, Lemaoult J, Mateizel I, Cauffman G, Horn PA, Carosella ED, Devroey P, De Waele M, Rebmann V, Vercammen M. HLA-G Expression in Human Embryonic Stem Cells and Preimplantation Embryos. J Immunol. 2011; 186(4): 2663-71 5.6
   
10. Schulte I, Hitziger T, Giugliano S, Timm J, Gold H, Heinemann FM, Khudyakov Y, Strasser M, König C, Castermans E, Mok JY, van Esch WJ, Bertoletti A, Schumacher TN, Roggendorf M. Characterization of CD8+ T-cell response in acute and resolved hepatitis A virus infection. J Hepatol. 2011; 54(2): 201-8 7.8
   
11. Kleinbongard P, Böse D, Baars T, Möhlenkamp S, Konorza T, Schöner S, Elter-Schulz M, Eggebrecht H, Degen H, Haude M, Levkau B, Schulz R, Erbel R, Heusch G. Vasoconstrictor Potential of Coronary Aspirate From Patients Undergoing Stenting of Saphenous Vein Aortocoronary Bypass Grafts and Its Pharmacological Attenuation. Circ Res. 2011; 108(3): 344-52 9.2
   
12. Warlich E, Kuehle J, Cantz T, Brugman MH, Maetzig T, Galla M, Filipczyk AA, Halle S, Klump H, Schöler HR, Baum C, Schroeder T, Schambach A. Lentiviral Vector Design and Imaging Approaches to Visualize the Early Stages of Cellular Reprogramming. Mol Ther. 2011; 19(4): 782-9 6.2
   
13. Rizzo R, Vercammen M, van de Velde H, Horn PA, Rebmann V. The importance of HLA-G expression in embryos, trophoblast cells, and embryonic stem cells. Cell Mol Life Sci. 2011; 68(3): 341-52 6.1
   
Buchbeiträge  
   
Horn PA. (2011): Reprogrammierung von Stammzellen. In: Anna Seemüller (Hrsg.): Transformationen - Interdisziplinäre Betrachtungen. Cuvillier Verlag Göttingen, S. 115–124 (ISBN 978-3-86955-878-3)  
   
Klump H, Elter-Schulz M. Herausforderungen der Transfusionsmedizin - Blutprodukte für Patienten in Hämatologie und Onkologie. WTZ-Journal 3, 2011; 16-19 (LUKON Verlagsgesellschaft mbH · ISSN: 1869-5892)  
   
Klump H, Horn PA. Somatische Gentherapie von blutbildenden Stammzellen (CME-Fortbildung). Transfusionsmedizin 2011; 1–12 (Georg Thieme Verlag KG · VNR 2760512011062200204 · ISSN 2191-8805ISSN 2191-8805)  
   
   
2010  
   
1. Lindemann M, Heinemann FM, Horn PA, Witzke O. Immunity to pneumococcal antigens in kidney transplant recipients. Transplantation. 2010; 90(12): 1463-7 3.7
   
2. Wild CA, Brandau S, Lindemann M, Hoffmann TK, Lang S, Bergmann C.: Toll-like receptors in regulatory T cells of patients with head and neck cancer. Arch Otolaryngol Head Neck Surg. 2010; 136(12): 1253-9 1.8
   
3. Stocking C, Grez M, Fehse B, von Laer D, Itoh K, Prassolov V, Nowock J, Kühlcke K, Just U, Schröder T, Klump H, Schiedlmeier B, Grassman E, Meyer J, Li Z, Schambach A, Modlich U, Kustikova O, Galla M, Bode J, Zander A, Baum C. Cell and virus genetics at the roots of gene therapy, retrovirology, and hematopoietic stem cell biology: Wolfram Ostertag (1937-2010). Hum Gene Ther. 2010; 21(11): 1501-3 4.2
   
4. Sattler KJ, Elbasan S, Keul P, Elter-Schulz M, Bode C, Gräler MH, Bröcker-Preuss M, Budde T, Erbel R, Heusch G, Levkau B. Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease. Basic Res Cardiol. 2010; 105(6): 821-32 5.9
   
5. Figueiredo C, Goudeva L, Horn PA, Eiz-Vesper B, Blasczyk R, Seltsam A. Generation of HLA-deficient platelets from hematopoietic progenitor cells. Transfusion. 2010; 50(8): 1690-701 2.9
   
6. Lindemann M, Nyadu B, Heinemann FM, Kribben A, Paul A, Horn PA, Witzke O. High negative predictive value of an amplified flow cytometry crossmatch prior to living donor kidney transplantation. Hum Immunol. 2010; 71(8): 771-6 3.1
   
7. Rebmann V, Switala M, Eue I, Grosse-Wilde H. Soluble HLA-G is an independent factor for the prediction of pregnancy outcome after ART: A German Multi-Centre Study. Hum Reprod. 2010; 25(7): 1691-8 3.9
   
8. Nückel H, Switala M, Sellmann L, Horn PA, Dürig J, Dührsen U, Küppers R, Grosse-Wilde H, Rebmann V. The prognostic significance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemia. Leukemia. 2010; 24(6): 1152-9 8.6
   
9. Schütt P, Schütt B, Switala M, Bauer S, Stamatis G, Opalka B, Eberhardt W, Schuler M, Horn PA, Rebmann V. Prognostic relevance of soluble human leukocyte antigen-G and total human leukocyte antigen class I molecules in lung cancer patients. Hum Immunol. 2010; 71(5): 489-95 3.1
   
10. Hemeda H, Jakob M, Ludwig AK, Giebel B, Lang S, Brandau S. Interferon-gamma and tumor necrosis factor-alpha differentially affect cytokine expression and migration properties of mesenchymal stem cells. Stem Cells Dev. 2010; 19(5): 693-706 4.1
   
11. Röth A, Peine S, Dührsen U. Paroxysmal nocturnal hemoglobinuria turning Coombs-positive. Int J Hematol. 2010; 91(2): 159-60 1.3
   
12. Bayerer B, Engelbergs J, Savidou I, Boes T, Kuper M, Schorn CF, Wissmann A, Knop D, Diener HC, Limmroth V. Single nucleotide polymorphisms of the serotonin transporter gene in migraine - an association study. Headache. 2010; 50(2): 319-22 3.1
   
13. Wurm M, Schambach A, Lindemann D, Hanenberg H, Ständker L, Forssmann WG, Blasczyk R, Horn PA. The influence of semen-derived enhancer of virus infection on the efficiency of retroviral gene transfer. J Gene Med. 2010; 12(2): 137-46 2.9
   
14. Moog R, Reichenberg S, Hoburg A, Müller N. Quality of methylene-blue-treated fresh-frozen plasma stored up to 27 months.Transfusion. 2010; 50(2): 516-8. 3.5
   
15. Radtke S, Görgens A, Punzel M, Horn PA, Giebel B.Establishment of an extended in vitro assay to detect the most primitive human hematopoietic cells at a clonal level. J Stem Cells Regen Med. 2010; 6(2): 48  
   
16. Goergens, A; Beckmann, J; Rajendran, L; Horn, PA; Giebel, B. Functional analyses of cell polarity organization in human hematopoietic stem and progenitor cells. 2010; 6(2): 74  
   
Buchbeiträge  
   
Müller KD, Schmid EN, Lindemann M, Müller G, Mosel F, Rettenmeier AW, Michel R (2010): KC 5/2, an unusual endocytobiont of acanthamoebae and monocytic cells. Abstractband 2010, BIOSpektrum, Chefredakteur: C. Schreiber, Editoren: B. Trageser, Spektrum Akademischer Verlag, S. 101, FTP20.  
   
Esser S, von Krosigk A, Jäger H, Reuter S, Jablonka R, Heinemann F, Horn P, Lindemann M (2010). Detektion der Abacavir-Hypersensitivität mittels ELLISpot-Methode. In: Hoffmann/Jäger (Ed.): HIV/AIDS besiegen: Visionen der Heilung; AIDS und HIV-Infektionen in Klinik und Praxis, Monographiereihe, Verlag Wiley-Blackwell, Berlin, 13: 9.  
   
Rebmann V. Grosse-Wilde H (2010): Tumour-specific and tumour-associated antigens. In: Stavrou DK, Hagel C (Eds.): Immune Biology of Brain Tumours, Dustri-Verlag Dr. Karl Feiste Munich – Orlando, 7 -21.  
   
Rebmann V. Grosse-Wilde H (2010): Immunological mechanisms of tumour cell destruction. In:Stavrou DK, Hagel C (Eds.): Immune Biology of Brain Tumours, Dustri-Verlag Dr. Karl Feistle, Munich – Orlando, 23 - 31.  
   
Görgens A, Giebel B. (2010): Self-Renewal of Primitive Hematopoietic Cells: A Focus on Asymmetric Cell Division, Kapitel 3 in “Umbilical Cord Blood: A Future for Regenerative Medicine?” Editors: Suzanne Kadereit, Gerald Udolph. World Scientific Publishing, 51-75.  
   
2009  
   
1. DeLuca DS, Beisswanger E, Wermter J, Horn PA, Hahn U, Blasczyk R. MaHCO: an ontology of the major histocompatibility complex for immunoinformatic applications and text mining. Bioinformatics. 2009; 25(16): 2064-70 4.3
   
2. Nückel H, Switala M, Collins CH, Sellmann L, Grosse-Wilde H, Dührsen U, Rebmann V. High CD49d protein and mRNA expression predicts poor outcome in chronic lymphocytic leukemia. Clin Immunol. 2009; 131(3): 472-80 3.6
   
3. Henneberg-Quester KB, Fuchs N, Holtmann M, Knop D, Mueller N., Horn PA, Peine SO. Consistent Error Reporting Reduces Blood Sample Mislabelling. Transfus Med Hemother 2009; 36 (suppl 1): 56-7 3.5
   
4. Fleischmann G, Horn PA. Pluripotency and reprogramming: meeting report on the Fifth International Meeting of the Stem Cell Network North Rhine Westphalia. Cloning Stem Cells. 2009; 11(4): 473-5 2.6
   
5. Lindemann M, Dioury Y, Beckebaum S, Cicinnati VR, Gerken G, Broelsch CE, Wrighton-Smith P, Grosse-Wilde H. Diagnosis of tuberculosis infection in patients awaiting liver transplantation. Hum Immunol. 2009; 70(1): 24-8 3.1
   
6. Fleischmann G, Müller T, Blasczyk R, Sasaki E, Horn PA. Growth characteristics of the nonhuman primate embryonic stem cell line cjes001 depending on feeder cell treatment. Cloning Stem Cells. 2009; 11(2): 225-33 2.6
   
7. Rebmann V, Bartsch D, Wunsch A, Möllenbeck P, Golda T, Viebahn R, Grosse-Wilde H. Soluble total human leukocyte antigen class I and human leukocyte antigen-G molecules in kidney and kidney/pancreas transplantation. Hum Immunol. 2009; 70(12): 995-9 3.1
   
8. Müller T, Fleischmann G, Eildermann K, Mätz-Rensing K, Horn PA, Sasaki E, Behr R. A novel embryonic stem cell line derived from the common marmoset monkey (Callithrix jacchus) exhibiting germ cell-like characteristics. Hum Reprod. 2009; 24(6): 1359-72 3.8
   
9. Moog R. Feasibility and safety of triple dose platelet collection by apheresis. J Clin Apheresis. 2009; 24(6): 238-40 1.8
   
10. Cicinnati VR, Kang JY, Hou J, Lindemann M, Koop K, Tuting T, Gerken G, Beckebaum S. Interferon-alpha differentially affects homeostasis of human plasmacytoid and myeloid dendritic cells. J Interferon Cytokine Res. 2009; 29(3): 145-59 1.8
   
11. Wiegand J, Luz B, Mengelkamp AK, Moog R, Koscielny J, Halm-Heinrich I, Susemihl C, Bentzien F, Diekmann J, Wernet D, Karger R, Angert K, Schmitt-Thomssen A, Kiefel V, Lutter K, Hesse R, Kätzel R, Opitz A, Luhm J, Barz D, Leib U, Matthes G, Tillmann HL. Autologous blood donor screening indicated a lower prevalence of viral hepatitis in East vs West Germany: epidemiological benefit from established health resources. J Viral Hepat. 2009; 16(10): 743-8 3.3
   
12. Hinrichs J, Figueiredo C, Hirv K, Mytilineos J, Blasczyk R, Horn PA, Eiz-Vesper B. Discrimination of HLA null and low expression alleles by cytokine-induced secretion of recombinant soluble HLA. Mol Immunol. 2009; 46(7): 1451-7 3.6
   
13. Rajendran L, Beckmann J, Magenau A, Boneberg EM, Gaus K, Viola A, Giebel B, Illges H. Flotillins are involved in the polarization of primitive and mature hematopoietic cells. PLoS ONE. 2009; 4(12): e8290 2.1
   
14. Figueiredo C, Jaimes Y, Horn PA, Blasczyk R, Eiz-Vesper B. The new HLA-Cw*0524 allele increase the variability of position 49 in HLA-C. Tissue Antigens. 2009; 74(3): 258-9 2.1
   
15. Wienzek S, Verboom M, Blasczyk R, Bein G, Horn PA. DQB1*0323 is the result of a gene conversion event between a DQB1*06 and a DQB1*030303 allele. Tissue Antigens. 2009; 73(6): 624-5 2.1
   
16. Moog R. Retention of prospective donors: a survey about services at a blood donation centre. Transfus Apher Sci. 2009; 40(3): 149-52 1.0
   
17. Moog R. 2008 Congress of the ESFH in Düsseldorf, Germany. Transfus Apher Sci. 2009; 41(1): 23-6 1.0
   
18. Heinemann FM. HLA genotyping and antibody characterization using the Luminex (TM) multiplex technology. Transfus Med Hemother. 2009; 36(4): 273-78 0.5
   
19. Cicinnati VR, Hou J, Lindemann M, Horn PA, Sotiropoulos GC, Paul A, Gerken G, Beckebaum S. Mycophenolic acid impedes the antigen presenting and lymph node homing capacities of human blood myeloid dendritic cells. Transplantation. 2009; 88(4): 504-13 3.8
   
20. Schumann A, Lindemann M, Valentin-Gamazo C, Lu M, Elmaagacli A, Dahmen U, Knop D, Broelsch CE, Grosse-Wilde H, Roggendorf M, Fiedler M. Adoptive immune transfer of hepatitis B virus specific immunity from immunized living liver donors to liver recipients. Transplantation. 2009; 87(1): 103-11 3.8
   
Buchbeiträge  
   
Heinemann FM, Nyadu B, Kribben A, Paul A, Witzke O, Horn PA, Lindemann M (2009): Predictive value of the flow cytometry cross-match in living kidney transplantation. In: P.I. Terasaki (Ed.): Visuals of the 10th European Clinical Histocompatibility Workshop, Evian-les-Bains, France. One Lambda, Inc.: 10-1.  
   
Schumann A, Lindemann M, Fiedler M (2009): Transfer der Hepatitis-B-Immunität durch Leber-Lebend-Transplantation. In: Selbsthilfe Lebertransplantierter Deutschland e.V. (Ed.): Hepatologie. Lebenslinien, 1: 15-6.  
   
Fleischmann G, Figueiredo C, Seltsam A, Blasczyk R, Horn PA. (2009): Embryonic Stem Cells: MHC Expression and Immunogenicity of Stem Cell-Derived Cellular Therapeutics. In: Advances in Medicine and Biology. Volume 1, ISBN: 978-1-60876-863-9: 165-198  
   
2008              
   
1. Moog R. Therapeutic apheresis - Many ways to go Transfus Med Hemother. 2008; 35(1): 5-6 0.6
   
2. Moog R. Management strategies for poor peripheral blood stem cell mobilization. Transfus Apher Sci. 2008; 38(3): 229-36 0.9
   
3. Emmerich F, Schönemann C, Diederich G, Horn PA, Salama A. Identification of a novel HLA-DQB1 allele, HLA-DQB1*0632. Tissue Antigens. 2008; 71(1): 94-5 2.3
   
4. Albis-Camps M, Blasczyk R, Horn PA. Haplotype-specific sequence-based typing shows the novel allele HLA-A*030105. Tissue Antigens. 2008; 71(1): 85-6 2.3
   
5. Barsegian V, Mathias KD, Wrighton-Smith P, Grosse-Wilde H, Lindemann M. Prevalence of latent tuberculosis infection in German radiologists. J Hosp Infect. 2008; 69(1): 69-76 3.0
   
6. Schütt P, Rebmann V, Brandhorst D, Wiefelspütz J, Ebeling P, Opalka B, Seeber S, Nowrousian MR, Moritz T, Grosse-Wilde H. The clinical significance of soluble human leukocyte antigen class-I, ICTP, and RANKL molecules in multiple myeloma patients. Hum Immunol. 2008; 69(2): 79-87 2.6
   
7. Giebel B, Bruns I. Self-renewal versus differentiation in hematopoietic stem and progenitor cells: a focus on asymmetric cell divisions. Curr Stem Cell Res Ther. 2008; 3(1): 9-16 3.6
   
8. Wurm M, Horn PA. Reprogramming, regeneration, and the stem cell niche: meeting report on the 4th International Meeting of the Stem Cell Network North Rhine Westphalia. Cloning Stem Cells. 2008; 10(2): 183-8 2.7
   
9. Lindemann M, Rietschel F, Zabel M, Grosse-Wilde H. Detection of chromium allergy by cellular in vitro methods. Clin Exp Allergy. 2008; 38(9): 1468-75 4.1
   
10. Giebel B. Cell polarity and asymmetric cell division within human hematopoietic stem and progenitor cells. Cells Tissues Organs. 2008; 188(1-2): 116-26 2.4
   
11. Beier D, Röhrl S, Pillai DR, Schwarz S, Kunz-Schughart LA, Leukel P, Proescholdt M, Brawanski A, Bogdahn U, Trampe-Kieslich A, Giebel B, Wischhusen J, Reifenberger G, Hau P, Beier CP. Temozolomide preferentially depletes cancer stem cells in glioblastoma. Cancer Res. 2008; 68(14): 5706-15 7.5
   
12. Seidel MG, Peters C, Wacker A, Northoff H, Moog R, Boehme A, Silling G, Grimminger W, Einsele H. Randomized phase III study of granulocyte transfusions in neutropenic patients. Bone Marrow Transplant. 2008; 42(10): 679-84 2.9
   
13. Chan KM, Bonde S, Klump H, Zavazava N. Hematopoiesis and immunity of HOXB4-transduced embryonic stem cell-derived hematopoietic progenitor cells. Blood. 2008; 111(6): 2953-61 10.4
   
14. Giebel B, Punzel M. Lineage development of hematopoietic stem and progenitor cells. Biol Chem. 2008; 389(7): 813-24 3.0